Skip to content

DBVT

DBV Technologies S.A.

NASDAQ · Healthcare · Biotechnology · FR

$13.47
−1.68%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$1.3K
Net value (3m)
-18.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 31, 2026Mohideen Pharis · officer: Chief Medical OfficerSale464$2.70
Feb 2, 2026Mohideen Pharis · officer: Chief Medical OfficerSale534$4.86
Jan 14, 2026BAKER BROS. ADVISORS LP · directorM-Exempt25,005,240$0.00
Jan 14, 2026BAKER BROS. ADVISORS LP · directorM-Exempt2,299,656$0.00
Dec 19, 2025EPIC Bpifrance · other: Member of 10% owner groupSale2,036,990$4.84
Dec 19, 2025EPIC Bpifrance · other: Member of 10% owner groupSale40,000$5.28
Dec 19, 2025EPIC Bpifrance · other: Member of 10% owner groupSale1,292,103$4.19
Nov 25, 2025Mohideen Pharis · officer: Chief Medical OfficerA-Award44,000$0.00
Nov 25, 2025Mohideen Pharis · officer: Chief Medical OfficerA-Award253,000$2.90
Nov 25, 2025Mohideen Pharis · officer: Chief Medical OfficerSale6,496$2.88
Nov 25, 2025Mohideen Pharis · officer: Chief Medical OfficerSale1,624$2.77
Nov 24, 2025Boucinha Virginie · officer: Chief Financial OfficerA-Award32,000$0.00
Nov 24, 2025Trapp Kevin Michael · officer: Chief Commercial OfficerA-Award316,250$2.90
Nov 24, 2025Trapp Kevin Michael · officer: Chief Commercial OfficerA-Award55,000$0.00
Nov 24, 2025Tasse Daniel · director, officer: CHIEF EXECUTIVE OFFICERA-Award964,000$2.90
Nov 24, 2025Boucinha Virginie · officer: Chief Financial OfficerA-Award192,000$2.90
Jul 31, 2025Mohideen Pharis · officer: Chief Medical OfficerSale464$2.22
May 27, 2025Mohideen Pharis · officer: Chief Medical OfficerSale397$1.84
Mar 31, 2025BAKER BROS. ADVISORS LP · director, 10 percent owner: A-Award2,299,656$0.00
Mar 31, 2025BAKER BROS. ADVISORS LP · director, 10 percent owner: A-Award25,005,240$0.00
Jan 31, 2025Mohideen Pharis · officer: Chief Medical OfficerSale600$0.85
Dec 5, 2024Tasse Daniel · director, officer: CHIEF EXECUTIVE OFFICERA-Award813,200$0.89
Nov 27, 2024Mohideen Pharis · officer: Chief Medical OfficerSale565$0.57
Nov 27, 2024Mohideen Pharis · officer: Chief Medical OfficerSale342$0.53
Nov 25, 2024Mohideen Pharis · officer: Chief Medical OfficerA-Award35,000$0.00
Nov 25, 2024Mohideen Pharis · officer: Chief Medical OfficerSale2,350$0.54
Nov 25, 2024Boucinha Virginie · officer: Chief Financial OfficerA-Award113,000$0.75
Nov 25, 2024Boucinha Virginie · officer: Chief Financial OfficerA-Award19,000$0.00
Nov 25, 2024Mohideen Pharis · officer: Chief Medical OfficerA-Award215,000$0.75
Jul 31, 2024Mohideen Pharis · officer: Chief Medical OfficerSale1,785$0.98
Institutional positioning

13F filings over the trailing two quarters

New 31Increased 12Reduced 15Sold out 72
FilerActionSharesFiled
BIOIMPACT CAPITAL LLCIncreased5,213,361May 15, 2026
VIVO CAPITAL, LLCIncreased2,667,569May 20, 2026
ARTISAN PARTNERS LIMITED PARTNERSHIPReduced2,219,386May 13, 2026
SIREN, L.L.C.Unchanged1,857,362May 14, 2026
BAKER BROS. ADVISORS LPUnchanged1,461,425May 15, 2026
ADAR1 CAPITAL MANAGEMENT, LLCNew Position1,012,866May 18, 2026
PERCEPTIVE ADVISORS LLCNew Position964,391May 29, 2026
PATIENT SQUARE CAPITAL LPIncreased693,534May 15, 2026
OCTAGON CAPITAL ADVISORS LPUnchanged574,200May 15, 2026
IKARIAN CAPITAL, LLCUnchanged525,000May 15, 2026
REDMILE GROUP, LLCReduced491,340May 15, 2026
DUQUESNE FAMILY OFFICE LLCNew Position383,363May 15, 2026
MILLENNIUM MANAGEMENT LLCReduced318,959May 15, 2026
ATIKA CAPITAL MANAGEMENT LLCIncreased271,300May 14, 2026
Elmind Capital, LPNew Position265,000May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 31, 2026